Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Melnick

Showing results (201-210 of 230) with videos related to

Pageof 23
Sort By:
Haematologica|April 6, 2023
Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicityCristiana O'Brien, Tianyi Ling, Jacob M Berman, et al.
Nature|March 10, 2016
Corrigendum: Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemiaZhengshan Chen, Seyedmehdi Shojaee, Maike Buchner, et al.
Science Translational Medicine|November 25, 2016
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomasJill Bayliss, Piali Mukherjee, Chao Lu, et al.
Cancer Cell|April 16, 2015
Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemiaAlan H Shih, Yanwen Jiang, Cem Meydan, et al.
Cancer Cell|March 8, 2024
SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisionsQing Deng, Priya Lakra, Panhong Gou, et al.
Cancer Cell|December 7, 2010
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiationMaria E Figueroa, Omar Abdel-Wahab, Chao Lu, et al.
The Journal of Biological Chemistry|May 3, 2011
Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7qLi Zhou, Joanna Opalinska, Davendra Sohal, et al.
Cancer Cell|January 8, 2021
An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment PersistenceEugen Dhimolea, Ricardo de Matos Simoes, Dhvanir Kansara, et al.
Nature Chemical Biology|September 28, 2011
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90Kamalika Moulick, James H Ahn, Hongliang Zong, et al.
The Journal of Clinical Investigation|September 9, 2025
Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9Rui Guo, Yizhe Sun, Matthew Y Lim, et al.
Pageof 23

Showing results (201-210 of 230) with videos related to

Sort By:
Pageof 23
Haematologica|April 6, 2023
Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicityCristiana O'Brien, Tianyi Ling, Jacob M Berman, et al.
Nature|March 10, 2016
Corrigendum: Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemiaZhengshan Chen, Seyedmehdi Shojaee, Maike Buchner, et al.
Science Translational Medicine|November 25, 2016
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomasJill Bayliss, Piali Mukherjee, Chao Lu, et al.
Cancer Cell|April 16, 2015
Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemiaAlan H Shih, Yanwen Jiang, Cem Meydan, et al.
Cancer Cell|March 8, 2024
SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisionsQing Deng, Priya Lakra, Panhong Gou, et al.
Cancer Cell|December 7, 2010
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiationMaria E Figueroa, Omar Abdel-Wahab, Chao Lu, et al.
The Journal of Biological Chemistry|May 3, 2011
Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7qLi Zhou, Joanna Opalinska, Davendra Sohal, et al.
Cancer Cell|January 8, 2021
An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment PersistenceEugen Dhimolea, Ricardo de Matos Simoes, Dhvanir Kansara, et al.
Nature Chemical Biology|September 28, 2011
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90Kamalika Moulick, James H Ahn, Hongliang Zong, et al.
The Journal of Clinical Investigation|September 9, 2025
Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9Rui Guo, Yizhe Sun, Matthew Y Lim, et al.
Pageof 23